Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori
Hassan Tariq, 1, 2 Harish Patel, 1, 2 Muhammad Umar Kamal, 1 Naeem Abbas, 1, 2 Muhammad Ameen, 1 Sara Azam, 1 Kishore Kumar, 1, 2 Madhavi Ravi, 1, 2 Vamshidhar Vootla, 1, 2 Danial Shaikh, 1, 2 Vamsi Amanchi, 1 Ali N Hussain, 3 Jasbir Makker 1, 2 1Department of Medicine, BronxCare Health System, Bro...
Main Authors: | Tariq H, Patel H, Kamal MU, Abbas N, Ameen M, Azam S, Kumar K, Ravi M, Vootla V, Shaikh D, Amanchi V, Hussain AN, Makker J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-01-01
|
Series: | Clinical and Experimental Gastroenterology |
Subjects: | |
Online Access: | https://www.dovepress.com/reevaluation-of-the-efficacy-of-first-line-regimen-for-helicobacter-py-peer-reviewed-article-CEG |
Similar Items
-
Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
by: Eman T. Azab, et al.
Published: (2022-06-01) -
The Efficacy of Levofloxacin-Based Triple Therapy over Standard ClarithromycinBased Therapy for Eradication of Helicobacter Pylori
by: Haseeb Noor, et al.
Published: (2024-01-01) -
Characteristics of Helicobacter pylori Heteroresistance in Gastric Biopsies and Its Clinical Relevance
by: You-hua Wang, et al.
Published: (2022-02-01) -
The comparison of levofloxacin- and clarithromycin-based bismuth quadruple therapy regimens in Helicobacter pylori eradication
by: Abbas Arj, et al.
Published: (2020-01-01) -
The Efficacy of Levofloxacin versus Clarithromycin in Primary Quadruple Therapy for the Eradication of Helicobacter Pylori: A Prospective Randomized Controlled Clinical Trial Study
by: Vahid Sebghatollahi, et al.
Published: (2020-06-01)